We found 42 YouTube channels similar to Novartis
Both target audiences interested in innovation and science; the overlap on searches like pharmaceutical innovation and biopharma research trends is high, with TEDx Talks' content (65%) aligning broadly with Novartis' focus on drug development ecosystems.
They share interest in biopharma research trends and healthcare industry strategy, and while Yahoo Finance covers broader market news, its content relevance to drug development ecosystems parallels Novartis in 66% content alignment.
Both address health equity and access, yielding a 32% search overlap but high content alignment (69%), indicating a shared emphasis on global health challenges and policy implications similar to Novartis’ broader health access discourse.
PhRMA centers on the drug development ecosystem, mirroring Novartis’ core business; with a 78% content match, their material closely tracks industry-oriented drug development topics and policy context.
Shares focus on biopharma research trends and AI in drug discovery; their 73% content similarity indicates a strong alignment in strategic topics and technical depth with Novartis’ innovation narrative.
Both cover pharmaceutical innovation and digital health, and Health2Tech’s 77% content similarity shows a close alignment in exploring technology-enabled pharma advancements akin to Novartis.
36 additional channels that were close
| Rank | Relevance | Channel | Similarity | Subscribers | SERP | Appearances |
|---|---|---|---|---|---|---|
| #7 | 52% | AJMCtv MJH | 72% | 4.9K | 23% | 2 |
| #8 | 52% | Reuters Events Pharma | 78% | 2.7K | 12% | 3 |
| #9 | 51% | The American Journal of Healthcare Strategy | 73% | 1.4K | 19% | 3 |
| #10 | 51% | Forbes ▶ | 66% | 2.1M | 29% | 6 |
| #11 | 51% | CNBC Television ▶ | 68% | 3.3M | 25% | 4 |
| #12 | 50% | U.S. Food and Drug Administration ▶ | 66% | 192K | 26% | 8 |
| #13 | 49% | AbbVie | 72% | 7.7K | 14% | 3 |
| #14 | 49% | American Medical Association (AMA) ▶ | 68% | 265K | 20% | 6 |
| #15 | 48% | Bain & Company Insights | 71% | 23.2K | 14% | 1 |
| #16 | 48% | Pharmalytics | 69% | 1.1K | 15% | 3 |
| #17 | 47% | FocusRx | Customized Career Coaching ▶ | 66% | 20.6K | 19% | 4 |
| #18 | 47% | CISCRP | 72% | 7.9K | 10% | 2 |
| #19 | 47% | Cardinal Health | 69% | 20.6K | 14% | 1 |
| #20 | 47% | Merck Life Science | 70% | 6.9K | 11% | 1 |
| #21 | 46% | AHealthcareZ - Healthcare Finance Explained ▶ | 70% | 44.5K | 11% | 1 |
| #22 | 46% | BBC StoryWorks | 69% | 25.2K | 12% | 2 |
| #23 | 46% | NVIDIA | 70% | 2.1M | 10% | 4 |
| #24 | 46% | Harvard Online | 70% | 239K | 9% | 1 |
| #25 | 46% | Patient Power Europe | 67% | 1.4K | 14% | 1 |
| #26 | 45% | InterSystems Learning Services | 67% | 9.7K | 13% | 2 |
| #27 | 45% | Bio-Rad Laboratories | 66% | 80K | 14% | 1 |
| #28 | 45% | Good Morning America | 66% | 5.5M | 14% | 1 |
| #29 | 44% | Stanford Graduate School of Business ▶ | 68% | 2.7M | 9% | 1 |
| #30 | 44% | The Wall Street Journal ▶ | 63% | 6.6M | 15% | 2 |
| #31 | 44% | AWS Events | 67% | 172K | 10% | 5 |
| #32 | 44% | UCD Michael Smurfit Graduate Business School | 63% | 3.9K | 14% | 1 |
| #33 | 43% | This Week in Startups Clips | 65% | 10.9K | 11% | 1 |
| #34 | 43% | CareerVidz | 63% | 5.2M | 14% | 2 |
| #35 | 43% | Bloomberg Television ▶ | 62% | 3.1M | 14% | 1 |
| #36 | 42% | Help Me GMP | GMP GDP Pharma Training | 63% | 1.5K | 11% | 2 |
| #37 | 42% | ABC News (Australia) | 61% | 2.5M | 14% | 1 |
| #38 | 42% | CrashCourse ▶ | 60% | 16.9M | 14% | 4 |
| #39 | 42% | Let's Learn Public Health ▶ | 62% | 160K | 11% | 1 |
| #40 | 42% | Pen and Paper Economics | 63% | 2.4K | 10% | 2 |
| #41 | 40% | Academy 4 Social Civics | 61% | 6.3K | 9% | 1 |
| #42 | 40% | BBC World Service ▶ | 60% | 1.9M | 9% | 1 |
Novartis's biggest competitors on YouTube are TEDx Talks (79% match, 44.2M subscribers) and Yahoo Finance (58% match, 1.5M subscribers); University of Global Health Equity (55% match, 3.8K subscribers) is also listed. They share a focus on professional, educational, and health-related content that appeals to audiences interested in science, medicine, and corporate/government health topics.
Novartis creates educational and corporate content related to pharmaceuticals, research, and ESG initiatives, evidenced by titles like Culture is built in the everyday moments, 2023 Highlights, Novartis Strategic Growth Highlights, On-going Commitment to ESG and Access to Medicines, and Focused Disease Areas for a Stronger Business Model. The channel averages about 80.2K views per video, with a rough upload frequency indicated by recent videos and an average view count per video.
We analyze Novartis's recent videos, generate topic-relevant search queries, check YouTube search results, and compare the meaning of each channel's content to measure similarity. The result is a ranked list sorted by SERP overlap, semantic similarity, and search appearances.
Discover similar channels for any YouTube creator